Cargando…
A randomized, double‐blind, placebo‐controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS‐CoV‐2 vaccine SCoK in adults
BACKGROUND: To determine an appropriate dose of, and immunization schedule for, a vaccine SCoK against COVID‐19 for an efficacy study; herein, we conducted randomized controlled trials to assess the immunogenicity and safety of this vaccine in adults. METHODS: These randomized, double‐blind, placebo...
Autores principales: | Luo, Deyan, Pan, Hongxing, He, Peng, Yang, Xiaolan, Li, Tao, Ning, Nianzhi, Fang, Xin, Yu, Wenjing, Wei, Mingwei, Gao, Hui, Wang, Xin, Gu, Hongjing, Mei, Maodong, Li, Xinwang, Zhang, Liangyan, Li, Deyu, Gao, Chunrun, Gao, Jinbang, Fei, Guoqiang, Li, Ying, Yang, Yuguo, Xu, Yi, Wei, Wenjin, Sun, Yansong, Zhu, Fengcai, Hu, Zhongyu, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473350/ https://www.ncbi.nlm.nih.gov/pubmed/36103390 http://dx.doi.org/10.1002/ctm2.1016 |
Ejemplares similares
-
An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
por: Li, Tao, et al.
Publicado: (2023) -
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
por: Luo, Deyan, et al.
Publicado: (2022) -
Acinetobacter baumannii adaptation to the host pH microenvironment is mediated by allelic variation in a single residue of BauA protein
por: Li, Tao, et al.
Publicado: (2023) -
Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice
por: Sun, Shihui, et al.
Publicado: (2021) -
B7 Family Molecule VSIG4 Regulates Intestinal Anti-Enterohemorrhagic Escherichia coli Immunity by Altering Gut Flora Diversity
por: He, Zhili, et al.
Publicado: (2021)